Advances in Hematology / 2017 / Article / Tab 2

Research Article

Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy

Table 2

Total donor chimerism on day 30.

Chimerism results at day 30P value
FluBu4 with PKFluBu4 with no PKBuCy

100% donor141716.311
86%–99%7155
<85%022

Bu, busulfan; Cy, cyclophosphamide; Flu, fludarabine; PK, pharmacokinetics.